Paper19787312
Comparisons of I-123 diagnostic and I-131 post-treatment scans for detecting residual thyroid tissue and metastases of differentiated thyroid cancer.
Iwano S and 5 others. Ann Nucl Med, 2009. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. Comparisons of I-123 diagnostic and I-131 post-treatment scans for detecting residual thyroid tissue and metastases of differentiated thyroid cancer. Papers, record 19787312. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19787312
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparisons of I-123 diagnostic and I-131 post-treatment scans for detecting residual thyroid tissue and metastases of differentiated thyroid cancer.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasm Metastasis | Major topic |
| Thyroid Gland | Major topic |
| Thyroid Neoplasms | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Female | |
| Humans | |
| Iodine Radioisotopes | |
| Male | |
| Middle Aged | |
| Radiation Dosage | |
| Radionuclide Imaging | |
| Whole Body Imaging | |
| Young Adult |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42572024 | Optimal timing of post-therapeutic [131I]NaI whole-body scintigraphy in predominantly low- and intermediate-risk differentiated thyroid cancer: a secondary analysis of prospectively acquired data and a structured literature review. | BMC Med Imaging | 2026 | https://conductscience.org/library/papers/42572024 | PubMed |
| 41718114 | The Role of 123I in the Management of Differentiated Thyroid Cancer: A Comprehensive Narrative Review. | Med Sci (Basel) | 2026 | https://conductscience.org/library/papers/41718114 | PubMed |
| 41515514 | Prediction of Treatment Response by Thyroid Bed Uptake on Post-Ablative Whole-Body Scan in Intermediate-Risk Patients with Papillary Thyroid Cancer. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/41515514 | PubMed |
| 40003609 | A Method for Calculating Small Sizes of Volumes in Postsurgical Thyroid SPECT/CT Imaging. | Life (Basel) | 2025 | https://conductscience.org/library/papers/40003609 | PubMed |
| 39941793 | Current and Emerging Radiotracers and Technologies for Detection of Advanced Differentiated Thyroid Cancer: A Narrative Review. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/39941793 | PubMed |
| 37109490 | A Neck-Thyroid Phantom with Small Sizes of Thyroid Remnants for Postsurgical I-123 and I-131 SPECT/CT Imaging. | Life (Basel) | 2023 | https://conductscience.org/library/papers/37109490 | PubMed |
| 36839858 | Evaluation of Therapeutic Efficacy and Imaging Capabilities of 153Sm2O3-Loaded Polystyrene Microspheres for Intra-Tumoural Radionuclide Therapy of Liver Cancer Using Sprague-Dawley Rat Model. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36839858 | PubMed |
| 36093082 | A semiquantitative study of the optimal whole-body imaging time after 131I therapy for differentiated thyroid cancer. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36093082 | PubMed |
| 29531251 | Predicting 131I-avidity of metastases from differentiated thyroid cancer using 18F-FDG PET/CT in postoperative patients with elevated thyroglobulin. | Sci Rep | 2018 | https://conductscience.org/library/papers/29531251 | PubMed |
| 29086115 | Molecular imaging of advanced thyroid cancer: iodinated radiotracers and beyond. | Med Oncol | 2017 | https://conductscience.org/library/papers/29086115 | PubMed |
| 26897715 | Novel Approaches to Thyroid Cancer Treatment and Response Assessment. | Semin Nucl Med | 2016 | https://conductscience.org/library/papers/26897715 | PubMed |
| 26085858 | Relations Between Pathological Markers and Radioiodine Scan and (18)F-FDG PET/CT Findings in Papillary Thyroid Cancer Patients With Recurrent Cervical Nodal Metastases. | Nucl Med Mol Imaging | 2015 | https://conductscience.org/library/papers/26085858 | PubMed |
| 23724150 | Clinical significance of discordant findings between pre-therapy (123)I and post-therapy (131)I whole body scan in patients with thyroid cancer. | Int J Clin Exp Med | 2013 | https://conductscience.org/library/papers/23724150 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19787312
GET https://conductscience.org/api/papers/v1/19787312/authors